Sanofi Signs Benitec's closest competitor Voyager for $845M, page-3

It may very well be that we are stuck in a 'mindset' that efficacy is the key to SP . Frustrating when we hear and see these kind of collaborations but we ( or at least I ) did , by default , put faith/ money into the current direction of the company . Just have to suck it in and hopefully the board is recognising that Australia is all about resources and BLT has to move out . The Sanofi deal with Voyager makes the 3 bucks value of an analyst (recently) a bit on the lower end perhaps ?
Sigh, sigh and big Sigh !!!!!